Abbott price target raised to $141 from $133 at Barclays

Barclays analyst Matt Miksic raised the firm’s price target on Abbott to $141 from $133 and keeps an Overweight rating on the shares. The analyst views the post-earnings pressure in the stock as unwarranted. The stock is attractive at current levels, backed up by a sum-of-parts analysis, the analyst tells investors in a research note.